Healthcare -
Biotechnology - NASDAQ - US
$ 61.53
0.457 %
$ 11.7 B
Market Cap
37.07
P/E
BMRN - COST OF REVENUE
Cost of Revenue BMRN - BioMarin Pharmaceutical Inc.
577 M
LAST VALUE
10.75%
2 YEAR CAGR
12.85%
5 YEAR CAGR
19.68%
10 YEAR CAGR